ENTITY
Hansoh Pharmaceutical Group

Hansoh Pharmaceutical Group (3692 HK)

171
Analysis
Health CareChina
Hansoh Pharmaceutical Group Company Limited operates as a pharmaceutical company. The Company manufactures and sells anti-infectives, anti-neoplastic agents, diabetes drugs, and other products. Hansoh Pharmaceutical Group markets its products throughout China.
more
Refresh
26 Mar 2020 13:37

Trade/Investment Ideas from 2019/20 IPOs

Since the start of 2019 till date, we have covered 96 IPOs. Despite the market turmoil over the past two months, over a third, or 40 IPOs remain...

Logo
497 Views
Share
06 Feb 2020 17:56

HK Connect Flows: What Chinese Buy/Sell on the First Day After Chinese New Year?

In this note, we would take a quick look at the top buys and sells by Chinese investors on the first day of trading over the Hong Kong Connect...

Logo
357 Views
Share
16 Jan 2020 14:57

2019 Hong Kong IPO Analytics: How Did Insti and Retail Coverage Impact Deal Performance

Since the inception of our IPO research in 2015, the Aequitas Research team has covered over 452 IPOs, which raised over US$100m each, across the...

Logo
512 Views
Share
08 Jan 2020 17:38

2019 Hong Kong IPO Analytics: Highlight of Brokers’ and Sectors’ Performance

Since the inception of our IPO research in 2015, the Aequitas Research team has covered over 452 IPOs, which raised over US$100m each, across the...

Logo
656 Views
Share
05 Dec 2019 10:35

Hansoh Pharma's Lock-Up Expiry: Valuation and the Trade

Lock-up restriction for Hansoh Pharma's controlling shareholder, pre-IPO investors and cornerstone investors will expire on December 14th. We...

Logo
448 Views
Share
x